Product Description: Nefazodone hydrochloride (BMY-13754) is a potent and selective 5HT2A (Ki=5.8 nM) antagonist with moderate inhibition of 5-HT and noradrenaline uptake (IC50 of 290 and 300 nM, respectively). Nefazodone hydrochloride is a phenylpiperazine antidepressant with less alpha-adrenergic blocking activity[1][2].
Applications: Neuroscience-Neuromodulation
Formula: C25H33Cl2N5O2
References: [1]Pullar IA, et al. LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone. Eur J Pharmacol. 2000;407(1-2):39-46./[2]Ellingrod VL, et al. Nefazodone: a new antidepressant. Am J Health Syst Pharm. 1995;52(24):2799-2812.
CAS Number: 82752-99-6
Molecular Weight: 506.47
Compound Purity: 99.87
Research Area: Neurological Disease; Endocrinology
Solubility: DMSO : 50 mg/mL (ultrasonic)/H2O : 2 mg/mL (ultrasonic)
Target: 5-HT Receptor;Adrenergic Receptor
Deutsch
English
